|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
|
|
|
|||||||||||||||||||||||||
| Test | 06-NOV-2018 | Reference Range | Unit |
|---|---|---|---|
| Leukocytes [#/volume] in Blood by Automated count | 5.1 | 3.4 - 10.5 | 10*3/uL |
| Erythrocytes [#/volume] in Blood by Automated count | 5.1 | 4.2 - 5.7 | 10*6/uL |
| Hemoglobin [Mass/volume] in Blood | 14.4 | 12 - 16 | g/dL |
| Hematocrit [Volume Fraction] of Blood by Automated count | 47.2 | 36 - 48 | % |
| MCV [Entitic volume] by Automated count | 93.0 | 82 - 98 | fL |
| MCH [Entitic mass] by Automated count | 32.5 | 27 - 34 | pg |
| MCHC [Mass/volume] by Automated count | 35.7 | 31 - 36 | g/dL |
| Erythrocyte distribution width [Entitic volume] by Automated count | 41.6 | 36 - 56 | fL |
| Platelets [#/volume] in Blood by Automated count | 414.5 | 150 - 450 | 10*3/uL |
| Platelet distribution width [Entitic volume] in Blood by Automated count | 252.8 H | 11.6 - 17.4 | fL |
| Platelet mean volume [Entitic volume] in Blood by Automated count | 10.8 | 9.4 - 14 | fL |
| Test | 06-NOV-2018 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 6.1 | 4.5 - 6.4 | % |
| Glucose [Mass/volume] in Blood | 98.5 | 70 - 140 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 19.3 | 7 - 43 | mg/dL |
| Creatinine [Mass/volume] in Blood | 0.7 | 0.7 - 1.1 | mg/dL |
| Calcium [Mass/volume] in Blood | 9.8 | 8.5 - 10.4 | mg/dL |
| Sodium [Moles/volume] in Blood | 138.1 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 4.2 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Blood | 102.2 | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 28.1 | 22 - 32 | mmol/L |
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| All measured parameters are within normal limits except for a markedly elevated platelet distribution width, which may indicate increased platelet size variability, possibly due to platelet activation or turnover. No evidence of anemia, renal dysfunction, or electrolyte imbalance. Glycemic control is at the upper end of normal. Correlation with clinical context and possible follow-up of platelet indices is recommended. |